Similarly, the Pro-B subcluster characterized by RPS29, B2M, and enrichment of the BCR pathway corresponds with published evidence linking BCR signaling to glucocorticoid resistance in B-ALL (26, 28). The gene discussed is B2M; the disease is acute lymphoblastic leukemia.